NeoPharm CO., LTD. (KOSDAQ:092730)
South Korea
· Delayed Price · Currency is KRW 13,280
+220 (1.68%)
Apr 29, 2025, 3:30 PM KST
NeoPharm CO., LTD. Revenue
In the year 2024, NeoPharm CO., LTD. had annual revenue of 119.01B KRW with 22.56% growth. NeoPharm CO., LTD. had revenue of 34.03B in the quarter ending December 31, 2024, with 25.04% growth.
Revenue
119.01B
Revenue Growth
+22.56%
P/S Ratio
1.72
Revenue / Employee
672.39M
Employees
177
Market Cap
204.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 119.01B | 21.91B | 22.56% |
| Dec 31, 2023 | 97.10B | 12.07B | 14.20% |
| Dec 31, 2022 | 85.03B | -2.90B | -3.30% |
| Dec 31, 2021 | 87.93B | 6.31B | 7.72% |
| Dec 31, 2020 | 81.63B | -1.61B | -1.94% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KT&G Corporation | 5,908.79B |
| Amorepacific | 3,885.11B |
| Samyang Foods | 1,728.02B |
| LG H&H | 6,811.92B |
| ORION | 3,104.34B |
| CJ Cheiljedang | 29.36T |
| APR Co., Ltd. | 722.75B |
| Dong Suh Companies | 488.86B |